Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIVAR trial of intravenous milrinone for cerebral vasospasm after aneurysmal subarachnoid hemorrhage
2019-002145-37Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milrinone in cerebral vasospasm, subarachnoid hemorrhage (SAH), sponsored by Centre Hospitalier Universitaire d'Angers. Started Oct 2019; status: active.
02
Drugs
milrinone
03
Conditions
cerebral vasospasmsubarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2019-002145-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002145-37.